ArcherDX

20 articles about ArcherDX

• Natera Files Additional Suit Against ArcherDX

  8/7/2020

  Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed suit yesterday against ArcherDX, Inc. for infringement of Natera's U.S. Patent No. 10,731,220 (the "'220 Patent"). The complaint was filed in the U.S. District Court of Delaware .

• 

  BioSpace Global Roundup, July 11

  7/11/2019

  Companies from across Europe, Asia and around the globe share pipeline and business updates.

• ArcherDX, Celgene Ink Worldwide Companion Diagnostic Agreement Relating to Investigational Drug CC-122

  11/8/2017

  Under the terms of the agreement, ArcherDX will use their patented Anchored Multiplex PCR technology combined with the Illumina MiSeqDx sequencing system and Archer Analysis bioinformatics software to develop the CDx.

• ArcherDX Expands Blood-Based Mutation Assay Portfolio With New Myeloid Panels

  8/2/2017

• ArcherDX Launches B Cell Receptor Sequencing Assays For Immune Repertoire Characterization At Immunology 2017

  5/16/2017

• ArcherDX Announces Strategic Partnership With Chinese Firm Helitec For NGS-Based Diagnostic Development

  4/4/2017

• ArcherDX Launches Immune Repertoire Sequencing Assays At American Society of Hematology 2016

  12/1/2016

• ArcherDX Release: Anchored Multiplex PCR Patent Is Issued To Inventors At Massachusetts General Hospital

  11/14/2016

• New Partnership Between Sophia Genetics And ArcherDX Continues To Democratize Data-Driven Medicine

  11/11/2016

• SeraCare Life Sciences Collaborates With ArcherDX On RNA Fusion Reference Standards

  11/10/2016

• Almac Diagnostics Partners With ArcherDX

  10/4/2016

• ArcherDX Dives Into Liquid Biopsy Research With Reveal ctDNA 28 Assay

  9/22/2016

• ArcherDX NGS Assays Receive Conditional Approval By New York State

  8/9/2016

• PierianDx And ArcherDX Announce Partnership Benefiting NGS Clinical Labs

  7/19/2016

• MPLN Partners With ArcherDX To Offer Archer NGS Assays To Global Biopharma Customers

  7/18/2016

• ArcherDX Partners With Illumina To Bring Leading Fusion Oncology Assays To Global Markets

  6/6/2016

• Cancer Genetics Partners With ArcherDX To Offer Archer NGS Assays As A Sequencing Service For Biotech And Pharma

  6/2/2016

• ArcherDX To Collaborate With Illumina On Next-Generation Sequencing-Based In Vitro Diagnostics Development

  5/31/2016

• ArcherDX Launches NGS Assays For Hematological Malignancy Profiling

  5/17/2016

• ArcherDX Launches Certified Service Provider Program, Pathgroup First Approved Provider

  2/17/2016